NURPF (Neuren Pharmaceuticals) Other Long-Term Liabilities : $-0.0 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Other Long-Term Liabilities?

Neuren Pharmaceuticals's other long-term liabilities for the quarter that ended in Dec. 2024 was $-0.0 Mil.

Neuren Pharmaceuticals's quarterly other long-term liabilities increased from Dec. 2023 ($0.0 Mil) to Jun. 2024 ($0.0 Mil) but then declined from Jun. 2024 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil).

Neuren Pharmaceuticals's annual other long-term liabilities stayed the same from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then declined from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($-0.0 Mil).

Neuren Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Neuren Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Other Long-Term Liabilities Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Neuren Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	0.03	-

Neuren Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Neuren Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (OTCPK:NURPF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

NK9:Germany NEU:Australia

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.